to evaluate the effectiveness of Pfizer and J&J SARS-CoV-2 vaccines against laboratory-confirmed COVID-19 hospitalisation among risk groups targeted for vaccination

Grant number: INV-035995

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2021
  • Known Financial Commitments (USD)

    $828,259
  • Funder

    Gates Foundation
  • Principal Investigator

    N/A

  • Research Location

    South Africa
  • Lead Research Institution

    Wits Health Consortium (Pty) Ltd
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A